EPHB2 (Ephrine Type-B Receptor 2, Tyrosine-protein Kinase Receptor EPH-3, DRT, Receptor Protein-Tyrosine Kinase HEK5, ERK, EPH-achtige Kinase 5, EK5, Tyrosine-protein Kinase TYRO5, Renale Carcinoom Antigen NY-REN-47, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5) (MaxLi

9007-83-4

[EPHB2]

2048

Human

Store product at 4 degree C in the dark. DO NOT FREEZE! Stable at 4 degree C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight750 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

Recognizes human EPHB2.

[EPHB2; EPHB2; DRT; EK5; ERK; CAPB; Hek5; PCBC; EPHT3; Tyro5; DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5; EK5; hEK5]

[EPHB2]

[ephrin type-B receptor 2 isoform 2; Ephrin type-B receptor 2; ephrin type-B receptor 2; EPH-like kinase 5; eph tyrosine kinase 3; elk-related tyrosine kinase; protein-tyrosine kinase HEK5; tyrosine-protein kinase TYRO5; renal carcinoma antigen NY-REN-47; tyrosine-protein kinase receptor EPH-3; developmentally-regula; EPH receptor B2; Developmentally-regulated Eph-related tyrosine kinase; ELK-related tyrosine kinase; EPH tyrosine kinase 3; EPH-like kinase 5; EK5; hEK5; Renal carcinoma antigen NY-REN-47; Tyrosine-protein kinase TYRO5; Tyrosine-protein kinase receptor EPH-3]

21396504

NP_004433.2

NM_004442.6

P29323